#PPCG
oh man, that is an incredibly good VFX reel for Nosferatu. www.youtube.com/watch?v=PpCg...
BlueBolt VFX Breakdown - Nosferatu
YouTube video by BlueBolt VFX
www.youtube.com
April 14, 2025 at 10:50 AM
It would not be unreasonable to interpret this as another genocide threat.

Please remember that merely *threatening* genocide violates the UN Convention on the PPCG.

Trump is blustering and full of shit as to our military capabilities right now, but this context should always be included.
"The president said the US is in constant communication with the Houthis, and that they've agreed not to fight the US. But the big headline here is the president said the Iranians better behave, and he's making a decision as to whether or not to blow up their nation."
September 21, 2026 at 12:22 AM
Nice #LightningTalk from @maxbeesley.bsky.social as part of #PPCG 2025 meeting

Using @10xgenomics.bsky.social #Visium & #inferCNV to spatially profile clonal heterogeneity & metastasis in #ProstateCancer

#SPACE_Study

@Pinkykotecha.bsky.social
@thineskrishna.bsky.social
@sandyfigiel.bsky.social
November 13, 2025 at 12:37 PM
This study reflects years of work by an incredible team led by Andreas Gruber, Andre Olsen, @bhernando.bsky.social, @cclkevin.bsky.social, @gmaci.bsky.social, @jweischenfeldt.bsky.social. Thanks to collaborators across PPCG, and to patients who donated samples & clinical data to enable this work.[5]
September 16, 2026 at 2:08 PM
Read our cool study out in @nature.com 🧬 great work by Andreas Gruber, André Vidas Olsen, @bhernando.bsky.social and Kevin Cheng. Co-led with @reimand.bsky.social and @gmaci.bsky.social
Read post here: tinyurl.com/3abceaev
Also great media coverage here: tinyurl.com/yz8mcb98
September 10, 2026 at 2:04 PM
Flying back from Bologna after the Pan Prostate Cancer Group #PPCG meeting. 3 days of fruitful discussions with lovely colleagues at the best venue I have ever been 🤩
May 14, 2025 at 5:15 PM
1/ NEW PAPER 🎉

🧵 We mapped the mutational processes shaping 959 prostate cancer genomes from the Pan Prostate Cancer Group (PPCG), integrating SBS, ID, CX and complex SV signatures. Eight footprints account for the processes in 85% of cases www.nature.com/articles/s41... @nature.com
Integrated signatures define mutational processes in prostate cancer - Nature
Eight integrated mutational footprints collectively explain the mutational processes in 85% of primary prostate cancer genomes.
www.nature.com
September 12, 2026 at 10:28 AM
Our paper on mutational processes in prostate cancer is out now in Nature! By analysing nearly 1,000 primary prostate cancer genomes from the Pan Prostate Cancer Group (PPCG), we identified the major mutational processes shaping prostate cancer genomes. www.nature.com/articles/s41... [1/5]
Integrated signatures define mutational processes in prostate cancer - Nature
Eight integrated mutational footprints collectively explain the mutational processes in 85% of primary prostate cancer genomes.
www.nature.com
September 16, 2026 at 2:08 PM
New paper out! "Genomic evolution shapes prostate cancer disease type". Really pleased to see this excellent bit of research final out. Part of the CRUK-ICGC prostate project & PPCG (panprostate.org). Led by David Wedge and Dan Woodcock.

doi.org/10.1016/j.xg...

@ueamedical.bsky.social
March 1, 2024 at 8:53 AM
Is Marvel Rivals Worth Your Time?
YouTube video by RamZaes
youtu.be
January 15, 2025 at 12:21 PM
If one paper out today wasn't enough, from the PanProstate Cancer Group (panprostate.org), we've got another outstanding paper. This one looking at biallelic epigenetic inactivation in the first PPCG data set.

Great work. Lucky to be involved.

doi.org/10.1038/s414...
Pan Prostate Cancer Group - Home
PanProstate Cancer Group website.
panprostate.org
September 9, 2026 at 7:53 PM
We hope this study will inspire further forecasting efforts across other molecular alterations. Thanks to all members of the @gmaci.bsky.social Lab & collaborators Paz Ares Lab #PPCG 14/
June 10, 2025 at 2:15 PM
The research is the first major publication from the Pan Prostate Cancer Group (PPCG), a global initiative jointly established by researchers at UEA and The Institute of Cancer Research (ICR) in London.
September 11, 2026 at 9:59 AM
3/ Substrate: 959 primary tumours from 1,001 PPCG donors, 7 countries, uniformly reprocessed, germline + somatic called the same way, median 7 yrs clinical follow-up. 4.7M SNVs, 292K indels, 74K SVs, 55K CNAs.
September 12, 2026 at 10:28 AM
17/ Enormous effort from co-first authors Andreas Gruber (Konstanz), André Olsen (BRIC Copenhagen) and Kevin Cheng (OICR), and from @gmaci.bsky.social, @reimand.bsky.social and @jweischenfeldt.bsky.social who co-led it. Thanks to #PPCG, to the men who donated samples, and to our funders.
September 12, 2026 at 10:28 AM
ARIZONA: CMS approves expansion of CHIP coverage to 9,700 more children & to let qualifying parents be paid caregivers:

acasignups.net/24/02/26/ari...
Arizona: CMS approves expansion of CHIP coverage to 9,700 more
Via the Centers for Medicare & Medicaid Services (CMS): February 16: CMS approved coverage expansions in Arizona through an amendmentof two policies, “Parents as Paid Caregivers” (PPCG) and “KidsCare
acasignups.net
February 26, 2024 at 9:05 PM
This research has been more than a decade in the making, and is the first major output of the Pan Prostate Cancer Group (PPCG), a global consortium with key local contributions from @unimelb.edu.au and @wehi-research.bsky.social
Pan Prostate Cancer Group - Home
PanProstate Cancer Group website.
panprostate.org
September 18, 2026 at 12:00 AM
A HEROIC Prostate Cancer Precision Health (PCaPH) Africa1K and Pan Prostate Cancer Group (PPCG) collaborative paper where through whole genome interrogation we reveal African specific candidate genes for prostate cancer germline testing, has gone live in @natcomms.nature.com.
doi.org/10.1038/s414...
Pathogenic variants reveal candidate genes for prostate cancer germline testing for men of African ancestry - Nature Communications
African ancestry is a known risk factor for prostate cancer development, but the genetic determinants of this are incompletely understood. Here, the authors identify 172 potentially pathogenic variants which are enriched in an African population.
doi.org
October 3, 2025 at 3:29 PM
This is just the beginning: another PPCG paper - also co-authored by Jung, Pope, Park and Hall - is already out in Nature Communications, another four papers have been accepted, and more are on the way.

Watch this space!
Recurrent mechanisms of biallelic epigenetic inactivation reveal new putative tumour suppressor genes in prostate cancer - Nature Communications
Epigenetic biallelic inactivation in prostate cancer remains to be explored. Here, the authors develop a computational method Epi2Hit that integrates the hemizygous genomic disruptions with patterns of hypermethylation at regulatory CpG sites to identify biallelic inactivation in tumour suppressor genes.
doi.org
September 18, 2026 at 12:00 AM
16/ Code: github.com/panprostate/mutational-signatures. Data via EGA (EGAS00001002876) and HMF. Everything is there – please take it apart.
GitHub - panprostate/mutational-signatures: PPCG mutational processes working group
PPCG mutational processes working group. Contribute to panprostate/mutational-signatures development by creating an account on GitHub.
github.com
September 12, 2026 at 10:28 AM
Integrated signatures define mutational processes in prostate cancer
We used data from the PPCG consortium of primary prostate cancer samples from a total of 1,001 prostate cancer donors with 1,172 tumour samples. Informed ethical consent was obtained at clinical follow-up, and was consistent with local research ethics and International Cancer Genome Consortium (ICGC) guidelines (https://icgc.org/). Ethical approval was obtained from local research ethical committees (details are provided in the Supplementary Methods). Analysis of SVs from genomic data Simple and complex SV classification method We conducted SV classification on the PPCG cohort using the cSVc tool18, including also SVs near TARBS and chromothripsis, both abundant in prostate cancer. First, exact breakpoint estimation from our WGS short-read sequencing data was conducted by using split-read information. Specifically, for each sample, we used the median of soft-clipped reads from the corresponding tumour BAM file to obtain corrected breakpoint positions. Next, we used ClusterSV18 to obtain clusters of SVs from the corrected SV data and we also used Battenberg68 to obtain segmented CN files from tumour and normal read coverage files. For each sample, we generated CN files segmented by corrected SV breakpoints by using the corrected SV data, the CN segmentation file, CN coverage and the tumour BAM file. Finally, we conducted...
www.nature.com
September 12, 2026 at 5:53 PM